Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

465.91 +17.11 (+3.81%)
Streaming Delayed Price Updated: 11:28 AM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
News headline image
Vertex to Announce Second Quarter 2025 Financial Results on August 4th
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:REGN),(NASDAQ:VRTX),(OTCQX:RHHBY),(NYSE:MRK) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Death
News headline image
What's Driving the Market Sentiment Around Vertex Pharmaceuticals? ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
3 No-Brainer Stocks to Buy in July ↗
Via The Motley Fool
News headline image
The Best Stocks to Invest $1,000 In Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence Government
News headline image
Vertex Pharma’s New Cystic Fibrosis Drug Granted Approval By EU ↗
Vertex announced on Tuesday that eligible patients in Ireland, Denmark, and Germany will have access to Alyftrek shortly after receiving regulatory approval from the relevant authorities. 
Via Stocktwits
News headline image
$100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
How Do Investors Really Feel About Vertex Pharmaceuticals? ↗
 
Via Benzinga
News headline image
3 S&P 500 Stocks with Mounting Challenges
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
Vertex Pharmaceuticals Unusual Options Activity ↗
 
Via Benzinga
News headline image
Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
3 Unpopular Stocks Facing Headwinds
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering ↗
FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research 
Via Benzinga
News headline image
Friday's session: gap up and gap down stock in the S&P500 index ↗
Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
2 Growth Stocks to Buy and Hold for 10 Years ↗
Via The Motley Fool
Topics Artificial Intelligence Economy World Trade
News headline image
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts ↗
 
Via Benzinga
News headline image
3 Growth Stocks You Can Buy Right Now Without Any Hesitation ↗
Via The Motley Fool
News headline image
$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or... 
Via StockStory
News headline image
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It ↗
Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
3 No-Brainer Healthcare Stocks to Buy in June ↗
Via The Motley Fool
News headline image
4 Monster Stocks to Buy and Hold for the Next Decade ↗
Via The Motley Fool
Topics Artificial Intelligence World Trade
News headline image
2 Top Stocks to Buy Right Now ↗
Via The Motley Fool
Topics Economy
News headline image
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗
Via The Motley Fool
Topics Economy Government Law Enforcement
News headline image
3 Top Growth Stocks to Buy in the Second Half of 2025 ↗
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
News headline image
2 Monster Growth Stocks to Buy and Hold for 10 Years ↗
Via The Motley Fool
Topics Bankruptcy
News headline image
5 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.